NCT04519476 2023-10-31Selinexor Treatment for Multiple Myeloma Patients Who Are Refractory to Lenalidomide-containing Therapy.OncotherapeuticsPhase 1 Unknown22 enrolled
NCT04818372 2021-11-12Dose Escalation and Expansion Study of CM313 in Subjects With Relapsed or Refractory Multiple Myeloma and LymphomaKeymed Biosciences Co.LtdPhase 1 Unknown87 enrolled